Laboratory Services
Navigating Analytical Requirements for GMP Viral Vectors
Laboratory Service Offering
At Andelyn Biosciences, we are at the forefront of pioneering analytical methodologies that are integral to the success of gene therapy products.
Our Laboratory Services encompass a full continuum of support for gene therapy programs, from preclinical studies through clinical manufacturing. Included under Laboratory Services are analytical development, method development, qualification and validation, in-process and release testing, stability programs, comparability studies, device compatibility evaluations, and Quality Control oversight aligned to cGMP. These Laboratory Services leverage advanced analytical methodologies to ensure data integrity, regulatory compliance, and reliable decision-making at every phase.
Our expertise helps accelerate your product's progress from early preclinical development to pivotal clinical trials. During the early phases of development, we offer tailored analytical development solutions and assistance with IND submissions, ensuring regulatory compliance and paving the way for successful transition into clinical trials. As your projects advance toward clinical manufacturing, we provide advanced analytics focused on strategic DMF support, ensuring your journey into human trials is compliant and strategically positioned for success.
At Andelyn Biosciences, the thoroughness of our analytical development underpins our commitment to advancing gene therapy, ultimately ensuring the highest quality, safety, and efficacy of our products for those who depend on them the most.
Facilities Driving Innovation and Breakthroughs
Explore the cutting-edge environments where innovation and quality meet. Andelyn proudly operates two specialized facilities, each designed to support different stages of gene therapy development and manufacturing. Discover how our advanced infrastructure and strategic locations accelerate your path to market.
Analytical Development
The stringent analytical requirements for viral vectors in gene therapy are crucial for ensuring product integrity and adherence to regulatory standards. Our promise of first-rate analytical testing and unfaltering regulatory adherence is not simply an assurance but a guarantee. Our Laboratory Services team develops, qualifies, and validates assays for identity, purity, potency, safety, and comparability, using state-of-the-art analytical methodologies appropriate to each development phase.
Quality Control
Working with the Analytical Development group, our Quality Control team maintains an unwavering focus on cGMP analytics, which are pivotal to the integrity of our clinical-phase productions, assuring manufacturing processes that are in strict compliance with the highest regulatory benchmarks.
Each assay developed by the Analytical Development team is first deployed in R&D quality control and must surpass stringent regulatory scrutiny prior to being operationalized within our GMP Quality Control domain. This structured approach reinforces not only our industry-leading position but also our dedication to being a trusted partner in pharmaceutical development.